Sepsis-associated neuroinflammation in the spinal cord

PLoS One. 2022 Jun 13;17(6):e0269924. doi: 10.1371/journal.pone.0269924. eCollection 2022.

Abstract

Septic patients commonly present with central nervous system (CNS) disorders including impaired consciousness and delirium. Today, the main mechanism regulating sepsis-induced cerebral disorders is believed to be neuroinflammation. However, it is unknown how another component of the CNS, the spinal cord, is influenced during sepsis. In the present study, we intraperitoneally injected mice with lipopolysaccharide (LPS) to investigate molecular and immunohistochemical changes in the spinal cord of a sepsis model. After LPS administration in the spinal cord, pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha mRNA were rapidly and drastically induced. Twenty-four-hour after the LPS injection, severe neuronal ischemic damage spread into gray matter, especially around the anterior horns, and the anterior column had global edematous changes. Immunostaining analyses showed that spinal microglia were significantly activated and increased, but astrocytes did not show significant change. The current results indicate that sepsis induces acute neuroinflammation, including microglial activation and pro-inflammatory cytokine upregulation in the spinal cord, causing drastic neuronal ischemia and white matter edema in the spinal cord.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines
  • Humans
  • Lipopolysaccharides
  • Mice
  • Microglia
  • Neuroinflammatory Diseases
  • Sepsis* / pathology
  • Spinal Cord / pathology

Substances

  • Cytokines
  • Lipopolysaccharides

Grants and funding

TT received the Grant-in Aid for Scientific Research (17K11076) from the Japan Society for the Promotion of Science (Tokyo, Japan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.